Product Images Methscopolamine Bromide

This text describes a medication containing 2.5 mg of Methscopolamine Bromide for oral administration. The tablets also list inactive ingredients and storage instructions. The product information provided mentions FDA approval and distribution details by i3 Pharmaceuticals, LLC. It is crucial to consult the package insert for recommended adult dosage and complete information.*

This text describes a medication containing 2.5 mg of Methscopolamine Bromide in tablet form for oral administration. It provides details on the usual adult dosage, impurity specifications, inactive ingredients (including microcrystalline cellulose and magnesium stearate), and storage instructions. The medication does not contain lactose and should be dispensed in a light-resistant container. The product is distributed by i3 Pharmaceuticals, LLC in Pennsylvania, USA. The tablets are made in the USA and come in a package of 1000 tablets. The information also includes the NDC code for the product.*

This text provides information about Methscopolamine Bromide tablets containing 5mg of the active ingredient. It lists the usual adult dosage, FDA-approved impurity specifications, inactive ingredients, and storage instructions. The tablets do not contain lactose and should be dispensed in a tight, light-resistant container. The product is distributed by i3 Pharmaceuticals, LLC in the USA. The package includes 1000 tablets and the NDC number is 72319-030-06. The tablets are for oral administration only.*

The text describes a tablet containing 5 mg of Methscopolamine Bromide, USP, with details such as dosage, inactive ingredients, and storage instructions. The tablet does not contain lactose. It should be dispensed in a light-resistant container and stored at 20° to 25°C. The product is distributed by i3 Pharmaceuticals, LLC in Warminster, PA. No detailed product information is available.*